Astral demerger: Stock drops 8% on 1:1 Chemie plan by FY27

Astral Ltd shares came under pressure in Monday’s session after the company announced a demerger of its chemicals business undertaking on a going concern basis. The chemicals division includes adhesives, paints and speciality chemicals, as per the company’s disclosure. The move is part of a broader composite scheme of arrangement that also proposes the amalgamation of Al-Aziz Plastics Private Limited into Astral Ltd. Investors reacted quickly to the restructuring update, pushing the stock down more than 6% intraday, with reports citing a fall of about 8% at the day’s lows.

The company said the demerger is intended to create sharper business focus, improve capital allocation and support margin improvement, alongside more transparent business segmentation and independent governance. Brokerages and market participants, however, have flagged that the post-demerger growth profile of the remaining businesses will be closely watched, particularly for the Paints and Adhesives segment that will remain with the listed entity.

What Astral’s board approved

Astral informed stock exchanges that its board approved a composite scheme of arrangement among Astral Limited, Astral Chemie Limited (formerly Astral Coatings Private Limited) and Al-Aziz Plastics Private Limited. Under the scheme, Astral will demerge and transfer its chemicals business undertaking, along with related assets and liabilities, into Astral Chemie. The transfer is proposed on a going concern basis.

The filing also states that the audit committee and independent directors’ recommendations were considered before approving the plan. The proposed restructuring does not involve any cash consideration, based on the details shared.

What stays with Astral after the demerger

Astral clarified that post demerger, all plumbing-related businesses will remain with Astral Ltd. This includes pipes and fittings, bathware and CPVC resin. In effect, the existing listed entity will continue to house the plumbing portfolio and associated operations.

This separation is designed to leave two focused businesses, with plumbing continuing in Astral and chemicals moving into the resulting entity, Astral Chemie.

What moves into Astral Chemie

The chemicals business being carved out includes adhesives, sealants, construction chemicals, paints and coatings, and speciality chemicals, as described in market reports and the company’s disclosures. Astral Chemie, currently described as a wholly owned subsidiary and formerly known as Astral Coatings Private Limited, is the entity that will receive these operations.

Astral said the demerged chemicals undertaking will move with all related assets and liabilities, reinforcing that the unit is expected to operate as a standalone business after the transaction becomes effective.

Shareholder entitlement: 1:1 shares in Astral Chemie

Astral stated that shareholders will receive one equity share of Astral Chemie for every one equity share held in Astral Ltd. The exchange ratio is 1:1. The company also specified the face value for the entitlement as Re 1 each for both Astral and Astral Chemie shares.

Following the demerger, Astral Chemie is proposed to be listed separately on both NSE and BSE, subject to regulatory approvals. Reports also noted that Astral Chemie will mirror Astral’s shareholding pattern after the distribution.

Market reaction: Astral stock drops 6% to 8%

The stock fell sharply on Monday, June 29, after the restructuring announcement. NSE data cited in reports showed Astral dropped 6.5% to an early low of Rs 1,390 after opening, compared with a previous close of Rs 1,486.90. Another market update said the stock opened 4.7% lower at Rs 1,417 on the NSE and slipped to an intraday low of Rs 1,385 in morning deals.

One report noted the shares fell 7.75% to hit a low of Rs 1,371. A Hindi market update cited an even deeper intraday move, stating the stock was down about 8.7% to Rs 1,357.10 at around 11:12 am. The price action reflected investor caution as the market assessed how the remaining businesses and the new listed chemicals entity would be valued.

Key numbers at a glance

Chemicals business scale: FY26 revenue and share

Brokerage commentary shared alongside the announcement said Astral’s chemicals portfolio generated revenue of Rs 1,266.3 crore in FY26. This was described as around 21% of Astral’s total turnover. The figure provides a reference point for investors trying to understand how much of the company’s current operations will sit in Astral Chemie post demerger.

The remaining business mix in Astral will therefore tilt more towards plumbing and building-material oriented categories, while the chemicals-led categories move into the separately listed entity.

Broker views: margin focus vs growth concerns

Experts quoted in market reports said the demerger is aimed at sharpening focus, improving capital allocation and improving margins. Another brokerage note said the demerger could eliminate a conglomerate discount and allow each business to be valued independently once the structure is in place.

At the same time, analysts flagged concerns that the demerger could potentially impact growth prospects for the remaining Paints and Adhesives segment, which was described as relatively sub-scale in commentary. Separately, JPMorgan downgraded Astral to ‘Neutral’ from ‘Overweight’ following the demerger news, reflecting a more cautious stance after the restructuring update.

Al-Aziz Plastics merger is part of the composite scheme

Alongside the chemicals demerger, the scheme provides for the amalgamation of Al-Aziz Plastics Private Limited into Astral Limited. The filing also stated that Al-Aziz Plastics, described as the transferor company, would be dissolved following the merger into Astral, described as the transferee company.

This part of the restructuring sits within the same composite arrangement that enables the separation of the chemicals business into Astral Chemie.

Timelines and what to watch next

Astral said the demerger should see completion by end-FY27. Other updates around the same development described the process as taking about 9-12 months to become effective, and also noted it could take 12 months or more, subject to approvals.

Near-term attention is likely to remain on regulatory steps required for the scheme, the record date for share entitlement, and the proposed listing of Astral Chemie on NSE and BSE. Investors will also track how Astral communicates segment-level performance once the businesses are separated more cleanly under the new structure.